Copyright
©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3449-3457
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3449
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3449
Case | Ref. | Age in yr | Presenting symptom | Histology | Immunoprofile positivity | FIGO stage | Surgery | Treatment | Outcome |
1 | Nguyen et al[9] | 70 | PMB | Pure LCNEC | Synaptophysin, chromogranin A, CD56, EMA | IVB | TAH, BSO, OMT | Etoposide, cisplatin | NED 6 mo |
2 | Nguyen et al[9] | 71 | PMB | Pure LCNEC | Synaptophysin, chromogranin A, CD56, P53, P16,PR | IVB | TAH, BSO, LND, OMT | Etoposide, cisplatin, octreotide | DOD 1 mo |
3 | Nguyen et al[9] | 52 | PMB | Pure LCNEC | NSE, synaptophysin | IC | TAH, BSO | Etoposide, cisplatin | DOD 7 mo |
4 | Kobayashi et al[10] | 52 | Abdominal pain | Pure LCNEC | Synaptophysin, chromogranin A, CD56 | IIIC | TAH, BSO, LND | Irinotecan, cisplatin, RT | DOD 10 mo |
5 | Makihara et al[28] | 73 | Abdominal distension | Pure LCNEC | Synaptophysin, chromogranin A, NSE, P53 | IVB | Refused surgery | Refused chemotherapy | DOD 5 wk |
6 | Makihara et al[28] | 73 | PMB | Pure LCNEC | Synaptophysin, chromogranin A, CD56, P53 | IIIC | TAH, BSO, LND, OMT | Cisplatin, irinotecan | Recurrence at 6 mo |
7 | Ogura et al[29] | 52 | Menorrhagia | Pure LCNEC | Synaptophysin, CD56, Ki67 | IIIC | None | None | DOD 1 mo |
8 | Mulvany et al[27] | 50 | PMB | Pure LCNEC | NSE, synaptophysin | IIIC | TAH, BSO, LND, OMT | Carboplatin, etoposide, RT | AWD 12 mo |
9 | Tu et al[15] | 51 | PMB | Pure LCNEC | CK, P53, CD56, synaptophysin | IVB | TAH, BSO, OMT, suboptimal debulking | Cisplatin, etoposide | DOD 3 mo |
10 | Shahabi et al[3] | 59 | PMB | Pure LCNEC | NSE, chromogranin A, synaptophysin, CD56 | IIIC | TAH, BSO, LND, OMT, suboptimal debulking | Carboplatin, paclitaxel, doxorubicin, etoposide, cisplatin, octreotide | DOD 12 mo |
11 | Suh et al[22] | 61 | Abdominal pain and rapid uterine enlargement | Pure LCNEC | synaptophysin, CD56 | IIIB | TAH, BSO, OMT | Etoposide/cisplatin, irinotecan/cisplatin, fluorouracil, leucovorin, irinotecan, RT | DOD 23 mo |
12 | Present case | 73 | PMB | Pure LCNEC | Cytokeratin AE1/AE3, chromogranin A, synaptophysin, CD56, P16 | IIIC | TAH, BSO | Paclitaxel, liposome, carboplatin | NED 15 mo |
- Citation: Du R, Jiang F, Wang ZY, Kang YQ, Wang XY, Du Y. Pure large cell neuroendocrine carcinoma originating from the endometrium: A case report. World J Clin Cases 2021; 9(14): 3449-3457
- URL: https://www.wjgnet.com/2307-8960/full/v9/i14/3449.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i14.3449